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A B S T R A C T
Background: Diagnosis of cancer through an emergency presentation is associated with worse clinical and pa-
tient experience outcomes. The proportion of patients with cancer who are diagnosed through emergency
presentations has consequently been introduced as a routine cancer surveillance measure in England. Welcome
reductions in this metric have been reported over more than a decade but whether reductions reflect true
changes in how patients are diagnosed rather than the changing case-mix of incident cohorts in unknown.
Methods: We analysed ‘Routes to Diagnosis’ data on cancer patients (2006–2015) and used logistic regression
modelling to determine the contribution of changes in four case-mix variables (sex, age, deprivation, cancer site)
to time-trends in emergency presentations.
Results: Between 2006 and 2015 there was an absolute 4.7 percentage point reduction in emergency pre-
sentations (23.8%–19.2%). Changing distributions of the four case-mix variables explained 19.0% of this re-
duction, leaving 81.0% unexplained. Changes in cancer site case-mix alone explained 16.0% of the total re-
duction.
Conclusion: Changes in case-mix (particularly that of cancer sites) account for about a fifth of the overall re-
duction in emergency presentations. This would support the use of adjustment/standardisation of reported
statistics to support their interpretation and help appreciate the influence of case-mix, particularly regarding
cancer sites with changing incidence. However, most of the reduction in emergency presentations remains
unaccounted for, and likely reflects genuine changes during the study period in how patients were being di-
agnosed.
1. Introduction
Evidence from several countries (including England, the US,
Canada, Sweden and France) documents that substantial proportions of
cancer patients are diagnosed in an emergency context [1,2], and that
this patient group experiences poorer clinical outcomes compared to
patients diagnosed through other routes [3,4]. Consequently in Eng-
land, population statistics on emergency cancer diagnoses are used as
routine measures for cancer surveillance [5].
Notable reductions in the proportion of Emergency Presentations
(EPs) among incident cancer cases have been reported in England [6].
Some of these reductions may reflect improvements in diagnostic
pathways, but others could reflect changes over time in patient case-
mix [1]. Cancer site and socio-demographic variables are strongly as-
sociated with the risk of diagnosis through an EP [7], and the case-mix
of incident cases is shifting. For example, prostate and lung cancer,
which are associated with either lower risk (prostate) or higher risk
(lung) of EP compared with other cancers, have contrasting incidence
trends (increasing for prostate; decreasing for lung) [5]. Considering
only those two cancer sites, one would expect a net reduction in the
overall proportion of EPs simply due to the changes in incidence,
however when considering all cancer sites and demographic factors the
situation is less clear. There is currently no formal evidence to describe
the degree by which changes in patient case-mix account for the
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observed decrease in EP.
Therefore, we aimed to examine the potential influence of case-mix
changes on EP time-trends, to help understand their potential con-
tribution and inform public reporting conventions.
2. Methods
2.1. Data
We analysed data on incident cancer patients 2006–2015, resident
in England. The National Cancer Registration and Analysis Service of
Public Health England assigns a diagnostic route (including EP) to all
cases, using an algorithmic rules-based approach applied to cancer re-
gistration, Hospital Episode Statistics, Cancer Waiting Times, and NHS
screening programme data [3]. EP is defined as diagnosis of cancer
following an A&E attendance, emergency hospital admission, emer-
gency between-hospital transfer, or emergency GP referral. Information
was available on year (of diagnosis), sex, age group, deprivation group
(based on the Income Domain of the Index of Multiple Deprivation of
the Local Super Output Area of patient’s residence), and cancer site (35
common and rarer cancer sites, defined by ICD-10 codes: Appendix 1).
2.2. Analysis
We first described associations between four case-mix variables
(sex, age, deprivation, cancer site) and diagnosis year with risk of EP,
and the distribution of these case-mix variables over time.
Our general analytical approach was to fit binary logistic regression
models (outcome: EP status; independent main effect variables: diag-
nosis year + all four case-mix variables). Given prior evidence, in-
teractions between each socio-demographic variable and cancer site
were also included [7]. To examine the global influence of changes over
time in respect of all four case-mix variables, we used the model to
predict proportions of EPs per year, had the sex-age-deprivation-cancer
site case-mix remained the same as for 2006.
To examine the contribution of each case-mix variable individually,
we used four simpler models, based on each variable alone (in-
dependent variables: year+ one case-mix variable, e.g. sex) and pre-
dicted the expected proportions of EP if case-mix had not changed.
Lastly, to examine the unique contribution of changes in the relative
frequency of each of the 35 cancer sites, we used a separate model per
cancer site (i.e. 35 models). In each instance, all incident cases of cancer
(not just those with the cancer of interest) were included in the model
(independent variables: year+ cancer site of interest [yes/no]).
3. Results
There were 2,641,428 incident cases of the 35 studied cancer sites
during the 10-year study period, of which 559,254 (21.2%) were di-
agnosed as emergencies, decreasing from 23.8% in 2006 to 19.2% in
2015 (Fig. 1; Appendix 2). Given a monotonic decrease in crude pro-
portions over time, we focus on the earliest and latest study years (2006
and 2015).
The risk of EP varied largely by age, deprivation, and cancer site,
with relatively little variation by sex (Appendix 2). Risks increased
notably with increasing age and deprivation. Melanoma, breast and
prostate cancer had relatively low risk of EP, and lung and colon cancer
relatively high. Compared to cancer patients diagnosed in 2006, those
diagnosed in 2015 tended to be younger (51.3% in 2015 aged 70 and
over vs 50.5% in 2006) and less deprived (Appendix 3). The relative
frequency of prostate cancer or melanoma cancer increased, and that of
breast or lung cancer decreased.
Between 2006 and 2015 the observed proportion of EPs decreased
by 4.7 percentage points (i.e. 23.81% to 19.15%). Had the distribution
of all four case-mix variables in 2015 been that of 2006, the reduction
would have instead been 3.8 percentage points (Table 1). That is,
changes in the distribution of sex-age-deprivation-cancer site case-mix
explained 19% of the observed decrease (0.9 of the 4.7 percentage
points). Alternatively, 81.0% of the reduction was not explained by
these changes.
Regarding individual contributions of each case-mix variable,
changes in the distribution of sex or age explained little of the above
reduction in proportion of EPs (–0.2% and 1.8%, respectively, Table 1).
[Negative contributions, such as for sex, indicates that had the sex
distribution been the same in 2015 as in 2006, the proportion of EPs in
2015 would have been even lower than that observed]. Changes in
deprivation case-mix explained 3.9% of the total reduction, while
changes in cancer site case-mix had the strongest influence by far, ex-
plaining 16.0%.
The specific contribution of each cancer site to the observed de-
crease in EPs is detailed in Fig. 2. Cancer of unknown primary was by
far the biggest individual contributor (11.1% of the observed decrease),
followed by melanoma (3.8%), prostate (2.2%), and lung (1.9%). Small
intestinal, rectal, and liver cancers had negative contributions of –1.5%
to –0.8%. Fig. 3 shows whether each cancer site is associated with a
relatively low/high risk of emergency presentation (X-axis), and whe-
ther its relatively frequency among the studied cancer sites increased/
decreased during 2006-15 (Y-axis). In general, the decreasing EP trend
due to changing case mix was partly explained by increased relative
frequency of lower-risk cancers for EP (e.g. melanoma, top-left quad-
rant) combined with decreased relative frequency of higher-risk cancers
(e.g. lung, bottom-right quadrant), though was tempered by increased
relative frequency of higher-risk cancers (e.g. liver, top-right quadrant)
and decreased relative frequency of lower-risk cancers (e.g. breast,
bottom-left quadrant).
4. Discussion
A fifth of the reduction in the percentage of cancer patients diag-
nosed through emergency presentations during 2006–2015 reflects
changes in patient case-mix, particularly the changing distribution of
different cancer sites. Up to four-fifths of the decrease could reflect
genuine changes in how patients are diagnosed as it is not explained by
changes over time in key patient characteristics.
Crude proportions of emergency presentations reflect the burden of
emergency presentations in the population, which is the appropriate
Fig. 1. Crude and predicted* proportions of emergency presentation by year of
diagnosis.
*Had sex, age group, deprivation group, and cancer site case-mix stayed the
same as in 2006. Predictions made using a logistic regression model fitted to
2006-15 data, where emergency presentation was the outcome, and in-
dependent variables were diagnosis year, sex, age group, deprivation group,
cancer site, and interaction terms sex*cancer site, age group*cancer site, and
deprivation*cancer site.
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Fig. 2. Relative proportion* of observed absolute decrease (between 2006 and
2015) in EPs attributable to changes in cancer site case-mix (overall [blue bar]
and individual cancer sites [red bars]). (For interpretation of the references to
colour in this figure legend, the reader is referred to the web version of this
article).
*Had sex, age group, deprivation group, and cancer site case-mix stayed the
same as in 2006. Predictions made using a logistic regression model fitted to
2006-15 data, where emergency presentation was the outcome, and in-
dependent variables were: year and a) in the case of all cancer sites, a variable
for cancer site; b) in the case of each individual cancer site, a dummy variable
representing that particular site.
ALL=Acute Lymphoblastic Leukaemia; AML=Acute Myeloid Leukaemia;
CLL=Chronic Lymphocytic Leukaemia; CML=Chronic Myeloid Leukaemia;
CUP=Cancer of Unknown Primary; HL = Hodgkin Lymphoma; NHL=Non-
Hodgkin Lymphoma.
Fig. 3. Change in the relative frequency of each studied cancer-site (between
2006 and 2015) plotted against the cancer site-specific risk of EP (in 2006).
Certain cancers with relatively low risk (e.g. melanoma) are becoming more
common (top-left quadrant), while some with relatively high risk less common
(lung, bottom-right quadrant). All other factors being equal, these would con-
tribute to downward trends. Contrasting patterns are observed in, for example,
rectal and liver cancer (bottom-left and top-right quadrants). These observa-
tions help to further interpret and contextualise the findings, and should be
interpreted together with Appendix 6 and estimates from the main analysis
model, indicating that the ‘net’ (overall) effect of cancer site case-mix changes
over time contributes to decreasing trends.
*The overall risk of EP, across the 35 cancers studied.
ALL=Acute Lymphoblastic Leukaemia; AML=Acute Myeloid Leukaemia;
CLL=Chronic Lymphocytic Leukaemia; CML=Chronic Myeloid Leukaemia;
EP=Emergency presentation; HL = Hodgkin Lymphoma; NHL=Non-
Hodgkin Lymphoma.
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information to be used for planning and administration of health care
services. Using time-trends in these crude counts for assessing im-
provement in diagnostic pathways is however problematic, because
they can be impacted by changes over time in case-mix. Case-mix ad-
justed proportions capture changes over time in the proportion of
emergency presentations, having removed the effect of changes in the
distribution of case-mix variables (i.e. regarding the cancer site, age,
sex and deprivation of incident cases). Further, by comparing crude and
case-mix adjusted estimates at the end of the study period, we can
appreciate the degree by which changes can be attributed to intrinsic
(i.e. case-mix) or extraneous (e.g. how patients are diagnosed) changes.
The findings build on prior inquiries on time-trends in emergency
presentations [8], for the first time exploring the contributions of
changes in case-mix. We have previously shown that for most of the 35
different cancer sites there were decreasing proportions of patients di-
agnosed through emergency presentations over time, though this was
not the case for 5 cancers (laryngeal, HL, anal, AML, ALL) [8]. Ex-
pectedly given these earlier findings, these 5 cancers tend to have a
‘neutral’ (neither positive nor negative) contribution as indicated by
their appearance in the ‘middle’ of Fig. 2. These considerations further
highlight the usefulness of considering individual cancer site and other
case-mix variable influences in trends in emergency presentations, and
also highlight that new early diagnosis strategies could be particularly
useful for some of these cancers. We used a large national dataset
spanning ten years, and EP status was derived via robust and stable
methods. Though we explored key case-mix variables, there may be
residual confounding by other socio-demographic variables (e.g. eth-
nicity); however, the potential contribution of such variables above and
beyond that of age-sex-deprivation-cancer site is likely limited.
The findings with regard to Cancer of Unknown Primary (CUP)
deserve special mention, as this patient group typically represents cases
of advanced stage and has a high proportion of emergency presenta-
tions (3rd highest among all 35 studied cancers, Supplementary
Material Appendix 2). Given its decreasing incidence, it is likely that in
later years, cases which would have been classified as CUP in earlier
years, would have been assigned to a known primary group (e.g. lung
cancer, colon cancer etc.). Thus, there is a gradual though subtle en-
richment of each cancer site (other than CUP) with tumours more likely
to be diagnosed as emergencies, as each site is progressively in-
corporating a small proportion of ‘ex-CUP’ cases, meaning that the
overall contribution of cancer site to the reduction in proportion EP
over time has been underestimated.
After adjustment for other case-mix variables (including cancer
site), we have observed a relatively small contribution of deprivation
case-mix differences in changes over time. This finding should be in-
terpreted as denoting relatively fewer cases of cancer being diagnosed
in more deprived groups progressively during the study period. This
should not be mis-interpreted as indicating that deprivation exerts no
risk on emergency presentation – it does indeed do so, and related in-
equalities are large and persistent [7,8].
Consistent with reporting conventions for other cancer surveillance
measures such as incidence or survival, routine surveillance statistics on
emergency presentations should, alongside crude estimates, account for
the influence of changing case-mix (such as by providing case-mix ad-
justed/standardised estimates). This can support interpretation and
help appreciate the influence of case-mix, particularly regarding cancer
sites with changing incidence [9,10].
To conclude, whilst changing case-mix has an influence, the vast
majority of the reduction in the percentage of cancer patients diagnosed
through an emergency presentation likely reflects changes in how pa-
tients are diagnosed. These changes have probably arisen from a com-
bination of patients presenting earlier and better diagnostic processes
post-presentation such as the use of the fast-track referral pathway
[3,11,12].
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